Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sangamo Therapeutics (SGMO) Non Operating Income (2024 - 2025)

Historic Non Operating Income for Sangamo Therapeutics (SGMO) over the last 4 years, with Q3 2025 value amounting to $107000.0.

  • Sangamo Therapeutics' Non Operating Income rose 14841.63% to $107000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.8 million, marking a year-over-year decrease of 25155.05%. This contributed to the annual value of $887000.0 for FY2016, which is 10580.05% up from last year.
  • Sangamo Therapeutics' Non Operating Income amounted to $107000.0 in Q3 2025, which was up 14841.63% from -$2.5 million recorded in Q2 2025.
  • Sangamo Therapeutics' Non Operating Income's 5-year high stood at $2.1 million during Q1 2024, with a 5-year trough of -$2.5 million in Q2 2025.